From Sea to Sight: Fucoidan Protects Against Oxidative Damage in Porcine Retina Organ Culture
Degeneration of retinal ganglion cells (RGCs) is a hallmark of glaucoma. As RGCs are vulnerable to oxidative imbalance, anti-oxidative strategies are of significant interest as novel therapeutic targets. Fucoidans, bioactive compounds derived from algae, are known to be anti-oxidative. Hence, we investigated if fucoidans have protective effects in a retina organ culture model. Porcine explants were pre-treated with fucoidan (<i>Fucus vesiculosus</i>; FVs) for 0.5 h (10 or 50 µg/mL). Afterwards, damage was induced through H<sub>2</sub>O<sub>2</sub> (500 µM; 3 h). Four groups were investigated: control, H<sub>2</sub>O<sub>2</sub>, 10 FVs + H<sub>2</sub>O<sub>2</sub>, and 50 FVs + H<sub>2</sub>O<sub>2</sub>. RGCs, glial cells, hypoxic/oxidative, apoptotic, and ferroptotic markers were examined by immunohistology, RT-qPCR, and a caspase assay. H<sub>2</sub>O<sub>2</sub> led to lower RGC numbers and RBPMS expression levels while FVs prevented this degeneration. An upregulation of glial expressions and more microglia/macrophages were observed in H<sub>2</sub>O<sub>2</sub> samples, mitigated by FVs. Anti-oxidative genes increased during stress but normalized with FVs. Apoptotic signaling increased while <i>GPX4</i> mRNA expression decreased with H<sub>2</sub>O<sub>2</sub>, both restored by FVs. Consequently, RGC loss was prevented through the attenuation of glial activation, inhibition of hypoxic/oxidative stress, and anti-ferroptotic/apoptotic action mediated by FVs. Advancing glaucoma research, this study emphasizes the therapeutic potential of FVs and offers new directions for future research.
Authors
- Alexa Klettner (ORCID: https://orcid.org/0000-0002-2709-1059)
- Philipp Dörschmann
- Leonie Deppe
- Stephanie Carolin Joachim
- H. Burkhard Dick
Institutions
- University Hospitals of the Ruhr-University of Bochum (DE)
- Christian-Albrechts-Universität zu Kiel (DE)
- Ruhr University Bochum (DE)
Publication Details
- Journal
- Marine Drugs
- Published
- 2026-02-24
- DOI
- https://doi.org/10.3390/md24030088
- Primary Topic
- Seaweed-derived Bioactive Compounds
- Type
- article
- Field-Weighted Citation Impact
- 0.00